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Summary A monoclonal antibody detecting amniotrophoblastic antigen 5T4 has shown reactivity against
various neoplastic cell lines and tumour specimens but with a relatively restricted normal tissue expression.
This antibody has been investigated as a potential indicator of premalignant changes identified as cervical
intra-epithelial neoplasia and malignant cervical lesions using immunohistochemistry on frozen tissue biopsies.
The basal cells of normal cervical stratified epithelium exhibited faint staining, but a general increase in
intensity and extent of specific labelling of this tissue was seen from the first premalignant stage through to
carcinoma. In most cases, this was in accordance with the distribution of dysplastic cells, and was accom-
panied by increased specific staining of the stromal tissue. All invasive squamous carcinomas of the cervix were
5T4 antigen positive. Common inflammatory non-malignant diseases did show a certain degree of epithelial
and stromal reactivity. These results, showing 5T4 reactivity with neoplastic and pre-neoplastic lesions, may
provide a quantitative basis for its potential use as a tumour marker in the immunochemical detection on
immunoassay of cervical cancer.
The 5T4 antigen described by Hole & Stern (1988) is defined
by a mAb which was raised against wheat germ agglutinin
(WGA) affinity purified syncytiotrophoblast plasma memb-
rane (Stmpm) glycoproteins. The 5T4 Ag is a glycoprotein
molecule of 72 kDa and 69 kDa, as detected by reduced and
unreduced SDS-PAGE respectively. Following N-glycanase
treatment, which cleaves the N-linked sugars, a 42 kDa core
protein remains. It exists on the cell surface as a monomeric
protein, apparently not associated covalently with any other
large molecules.
Immunohistochemical investigations of 5T4 expression in a
range of placental, uterine and adult normal and neoplastic
tissues has been performed on frozen sections (Hole & Stern,
1988; Southall et al., 1990). On full term placenta, the labell-
ing was restricted to villous syncytiotrophoblast, amniotic
epithelium, as well as extravillous cytotrophoblast of the
chorion laeve. There is no significant 5T4 expression in nor-
mal lymphoid tissues, heart, brain, small intestine, liver, lung,
bronchus, skeletal muscle, testis or ovary. Weak or moderate
reactions were found in the basal layer of stratified squamous
epithelium (cervix, oesophagus and skin), glandular
epithelium of endocervix and endometrium, mucosal glands
of stomach and large intestine and some excretory epithelium
of the pancreas.
While 5T4 antibody detects an antigen restricted in expres-
sion by normal tissues, it reacts with a variety of different
carcinomas including those from bladder, breast, cervix,
endometrium, kidney, lung, oesophagus, ovary and pancreas,
stomach and all non-seminomatous germ cell tumours of the
testes.
The low level of reactivity with the 5T4 mAb in normal
tissues suggests 5T4 antigen may be a useful tumour marker.
Some other trophoblast markers, e.g. placental alkaline phos-
phatase (PLAP) (Johnson, 1984), show significant expression
in normal tissues and yet have still proved to be of use in
both tumour localisation and diagnosis of malignancy
(Epenetos et al., 1985; McDicken et al., 1985). The reactivity
of the 5T4 mAb with invasive carcinoma of the cervix
(Southall et al., 1990 and unpublished observations) has
prompted a comprehensive investigation of this malignancy
and the premalignant changes.
The present view of cervical carcinoma is that it arises
from dysplastic precursor lesions in the reserve cells in the
basal layer of the stratified metaplastic epithelium. These
areas develop from proliferating basal cells which have
undergone some form of transformation, and gradually
spread throughout the whole epithelium. Cervical carcinomas
thus develop from a series of atypical changes which progress
in continuum to a stage of carcinoma in situ. This is prob-
ably the final premalignant state before the lesion invades the
underlying stroma becoming micro-invasive. The dysplastic
variations have been categorised as a series of changes in
cervical intraepithelia neoplasia (CIN) (Buckley et al., 1982;
Anderson, 1985). They have been graded from I to 3, with
CIN I representing less than a third of the dysplastic involve-
ment, located in the basal layer. CIN 2 with a third to
two-thirds involvement, and CIN 3 two-thirds to full thick-
ness involvement, equivalent to carcinoma in situ. At any
stage, the lesion may regress back to normality. Approx-
imately 90% of cervical neoplasms are squamous cell car-
cinomas; the remaining proportion are adenocarcinomas
(Buckley et al., 1988). A number of mAbs have been inves-
tigated to see if they could be of use in the histo-
pathological diagnosis of cervical neoplasia. H317 and H17-
E2 (McLaughlin et al., 1987); Cal, HMFGI and 2, 8.30.3
and 77.1 (Jha et al., 1984); Ha and La (Lindgren et al., 1985)
have all been widely documented on their reactions with
cervical neoplastic lesions, but their degree of reactivity in
normal cervical tissue has limited their potential use as diag-
nostics. Here we investigate the pattern of cellular labelling
using the mAb 5T4, in benign preneoplastic and malignant
lesions of the cervix. If the latter were distinguishable, a
powerful tool for diagnosing cervical neoplasia in biopsy
material and cervical cytology, with a basis for automated
screening, would be available.
Materials and methods
Preparation of tissuefor immunohistochemistry:.frozen
specimens
Placental tissue was washed in PBS (phosphate buffered
saline). One cm3 of tissue was then embedded in OCT com-
pound and snap frozen by immersing the specimen in CO2 ice
with isopentane, within I h post-partum. Frozen cervical
specimens were selected from a store at the Royal Liverpool
Women's Hospital (RLWH). These samples, from cone or
punch biopsies routinely submitted for histology, were
embedded in polycel, snap frozen and stored at - 70°C. The
specimens were cut at 7jtm thickness using a cryostat and
placed on slides (cleaned with ethanol and coated with poly-
L-lysine). The pathological assessment was obtained from the
records of examination of the specimens subjected to fixation
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in formal buffered saline, dehydration wax embedding and
haematoxylin and eosin staining.
Immunohistochemistry
The method described by Bulmer and Sunderland (1983) was
used for placental sections but modified for cervical sections.
Briefly, the slides were dried at room temperature for 30 min
before being washed in PBS. Endogenous peroxidase activity
was blocked in 3% H202 in ethanol, followed by three
washes with 2.5% sucrose/PBS and 2 x 1% bovine serum
albumin (BSA)/PBS. The sections were incubated with 10%
normal goat serum (NGS) (in 1% BSA/PBS) for 20 min
before the application of the first layer Ab. All reagents were
microfuged at 14,000 g for 10 min to remove debris before
use. The first layer test mAb was applied (ascites fluid diluted
1/100 in 1% BSA/PBS) and incubated for 1 h at room
temperature in a moist box. Subsequently, each slide was
washed individually three times in 1% BSA/PBS before hav-
ing the second layer peroxidase conjugated rabbit anti-mouse
(R anti-MIg) (Dako) diluted 1:50 in 1% BSA/PBS + 10%
normal human serum (NHS). After 1 h incubation (same
conditions as before), the slides were washed 2 x 1% NHS,
1% BSA/PBS and developed using 3'3' diaminobenzidine,
5 mg 10 ml-' PBS + 0.02% H202). The reaction was stop-
ped after 10 min by rinsing with tap water. The slides were
counterstained using Meyer's Haemalum, dehydrated by
passing up graded alcohols, fixed in xylene and mounted. All
experiments were performed using monoclonal antibodies
W6/32 to HLA.A.B.C and 10.2.16 to mouse Ia antigen as
ascites fluid in positive and negative controls respectively.
Detection ofST4 expression in cervical tissue
Tissue sections were selected on the basis of a previous
pathological diagnosis. Occasionally, on inspection, the
degree of CIN did not correspond with the initial diagnosis.
This was conceivable, as the area of tissue biopsy on which
the diagnosis was made was in a slightly different location to
that of the frozen one, and CIN is known to have a non-
uniform distribution. Alternatively, it might reflect the sub-
jective nature of defining degrees of dysplasia by different
pathologists. The slide specimens were thus reclassified if
necessary, and placed into the appropriate groups according
to the pathology of the epithelium. The groups were
categorised as follows: normal, metaplastic, HPV infected
without dysplasia, CIN 1, CIN 2 or CIN 3, with or without
HPV infection, invasive carcinoma and common non-malig-
nant cervical inflammatory disorders including hyperplasia,
chronic inflammation, cervicitis, glandular atypia, acanthotic
epithelium and radiation induced atypia. Sixty-six biopsy
specimens were investigated and each experiment was per-
formed with a positive and negative control (W6/32 and
10.2.16 respectively) and read independently by two
observers. The data presented represent agreement in the
scoring of the various specimens and where there was
sufficient material, the experiments were repeated (>50%).
Placental villous sections were included in each experiment to
ensure that the procedure was working optimally. The degree
of labelling was assessed as anything above that shown in the
negative control. A subjective estimation of the intensity of
the labelling was also made. The lower part of Figure I
outlines the uniform approach undertaken when judging the
distribution of the labelling.
Results
5T4 expression in cervical biopsy frozen sections
Table I and Figure 1 summarise the extent of 5T4 labelling
from the basal epithelium to the surface in 66 cone or punch
biopsies from the ectocervix. The data can be grouped in
several categories. The sections of 'normal' ectocervix,
squamous metaplasia and HPV infection without evident
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Figure I Relative antigen concentration in arbitrary units versus
different layers of epithelium of +, 'normal' cervix; 0,
squamous metaplasia and HPV infection without dysplasia; with
or without HPV: A, CIN 1; *, CIN 2; 0, CIN 3; 0, miscellan-
eous. The antigen concentrations were calculated from averaging
the subjective assessment in each layer and for the groups above.
dysplasia exhibited a similar phenotype in intensity and range
of distribution of 5T4 antigen. Nine of 17 showed labelling
confined to the basal cells of the epithelium; six showed faint
labelling throughout the epithelial layers and only two dem-
onstrated significant labelling to level C3. There was diffuse
cytoplasmic labelling associated with the connective tissue
stromal elements to the same degree as the basal layer:
columnar epithelium and glands when present were labelled.
These results are in the range of those described for cervical
tissue in a previous immunohistological study of 5T4 expres-
sion in normal and neoplastic tissues (Southall et al., 1990).
The above arbitrary grouping shows no obvious differences
from the specimens in the CIN I category (Table I, Figure 1).
The latter is characterised by the appearance of atypical
nuclei located in the lower third of the epithelium. It was
frequently noted that the 5T4 labelling was located in the
parabasal layers corresponding to the area of dysplasia
(Figure 2a, b).
From the data in Table I and Figure 1, it is apparent that
there is a progression through CIN 2 and CIN 3 to a more
extensive pattern and intensity of labelling with 5T4 mono-
clonal antibody. Figure 2c and d shows an example of CIN 2,
where dysplastic cells occupy two-thirds of the epithelial layer
with the sqaumous epithelium labelled from the reserve cell
layer to just below the surface layer. The staining is of higher
intensity than in that detected generally in the non-dysplastic
or CIN 1 specimens. Figure 2e and f shows an example of
the classical CIN 3 stage with large hyperchromatic nucleic
producing a high nuclear cytoplasmic ratio; the distribution
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Table I 5T4 antigen expression in non-dysplastic and dysplastic
Pathology
Normal ectocervix
Squamous
metaplasia
HPV without CIN
CIN I
CIN I with HPV
CIN 2
CIN 2 with HPV
CIN 3
CIN 3 with HPV
Invasive
carcinoma
Hyperplasia
Chronic
inflammation
Cervicitis and
glandular atypia
Acanthotic
epithelium
Radiation induced
atypia
cer
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associated with the abnormal cells. Fourteen of 15 CIN 3
showed labelling from the basal layer to just below the
surface epithelium; 9/15 exhibited labelling along the surface.
All five examples of squamous cell carcinoma showed
positive intense labelling of the malignant cells and surround-
ing stroma. Figure 2g and h shows an example of a non-
keratinised squamous cell carcinoma with invading cells
penetrating the stroma which are both strongly labelled and
which is clearly distinguished from the infiltrating
inflammatory cells which are unlabelled. In other examples,
the pattern of distribution of labelled cell is patchy with some
malignant cells showing no evidence of staining and the
stromal labelling varying in intensity.
The final group of miscellaneous conditions includes three
specimens of hyperplasia, two of chronic inflammation, two
of cervicitis and glandular atypia, and single examples of
acanthotic epithelium and radiation induced atypia. These
specimens were selected on the basis of their conventional
pathology and exhibited a range of labelling. The inflam-
matory infiltration response did not increase 5T4 expression
per se; the single example of acanthotic epithelium was
clearly labelled as were 2/3 of the hyperplastic epithelia. This
arbitrary grouping shows some tendency to higher levels of
5T4 expression in the centre layers but appears different from
the CIN 2 and CIN 3 groupings.
Discussion
- - + + +
-_- - + + + + Cervical cancer was responsible for 1,895 deaths in 1987 in
+ + + + + England and Wales (OPCS 1987, DH2 no. 14, HMSO). It is,
- + - + - + - + + + however, one of the few malignant conditions that can be
-- - - + prevented. Cytological screening is the most commonly emp-
- + + + + loyed method for detecting premalignant and early invasive
- - - + + + + lesions. This together with early treatment of premalignant - ++ + + + lesions has the potenti4l to reduce the mortality caused by
+ + + ++ + + cervical cancer. However, there is still an ever increasing need
+ + + + + + for improvement in the areas of detection and treatment,
+ + + + + + especially when the number of people presenting with CIN
+ + + + + + + + + may be increasing (Villard et al., 1989), and the current
+ + + + + + + + screening programme is preventing only 25% of unnecessary
- + + + + + + deaths (Hendry-Ibbs, 1987).
- + + + + + + A new approach using a tumour marker specific for cer-
+ + + + + + vical cancer may revolutionise current methods for screening,
++ + + + + + by offering the potential for automation of detection of a
+ ++ + ++ ++ tumour specific Ag from either serum or mucus samples or
- + + + + tmu pc
+ + + + + + + + solubilised biopsies. In the field of histopathology, the
+ + + + + + + markers may aid diagnosis and help prognosis. In treatment
+ + + + + + + procedures they may be of assistance in a proportion of
+ + + + + + + cervical carcinomas which metastasise, for imaging and drug
+ + + + + + + + targeting (Sikora ct al., 1984).
- + + + ± In the search to raise suitable mAbs which have a defined
+ + + + + + specificity towards 'oncofetal' antigens, immunisation with a
+ + source of developmental tissue has been used (Johnson et al., pithelial layers + + 1981). A commonly employed method is to use syncytio-
nour in stroma + + trophoblast microvillous plasma membrane (StMPM)
which
+ + is a product of placental extract (Smith et al., 1974). Placen-
+ + + + + + tal alkaline phosphatase (PLAP) has been identified using
- - - + - + - + mAbs, and these so far have shown the greatest clinical
+ + + + + potential (Travers & Bodmer, 1983). The mAbs H17-E2 and
- - - - + + H317 are the most commonly used, each recognising two
+ - + - + - + + different iso-forms of PLAP and have been investigated as
-+ - + - + - + - + potential tumour markers in cervical (McLaughlin et al.,
+ + + + 1987), ovarian (McDicken et al., 1985) and breast (McDicken
+ + + + + et al., 1983) neoplasms. In cervical cancer, no specific correla-
tion between the level of PLAP and disease status was found
in solubilised smears, biopsies, mucus swabs and serum.
Although a raised PLAP level was detected, it coincided with
the range expressed by normal tissue.
rrespond to the level of dysplasia. Observing the 5T4 antigenic distribution over a wide range
quently exhibited diffuse cytoplas- of malignant and pre-malignant conditions in cervical cancer,
I elements with an intensity similar a consistent pattern of staining for specific pathological
Where the morphology of dysplas- disorders was evident. Normal cervical epithelium, showed
it was evident that from the CIN 2 faint reactivity localised to the reserve cells only (Southall et
:hat the specific 5T4 labelling al., 1990). CIN, being the progressive transformation from
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Figure 2 Increased 5T4 labelling (b, d, f, h) associated with the progressive dysplastic conditions of CIN compared with irrelevant
antibody labelling (a, c, e, g,). a,b, Specimen with pathology assessed as mild dysplasia or CIN 1. Compared to the control, the 5T4
labelling is located to the basal layers containing some dysplastic cells. Above the level of C2, there is no significant 5T4 Ag
expression. The stroma is positive. c,dA Specimen with pathology assessed moderate dysplasia (CIN 2). Significant labelling of
uniform intensity is seen distributed from the basal to the surface epithelial layers (Cl -C4). Positive stroma is present. e,f, A
specimen of severe dysplasia (CIN 3) where the proliferating atypical reserve cells are seen penetrating the area of relatively
'normal' epithelium. The dysplastic cells located throughout the breadth of the epithelium are strongly labelled compared to the
normal ones. The surface layer of epithelium cells lying in the dysplastic area are strongly labelled compared to those which are
above the normal epithelium. g,h, Specimen is a non-keratinising squamous cell carcinoma of the cervix. The malignant epithelial
cells which have invaded the underlying stroma are strongly positive with no detectable 5T4 expression on the surrounding
inflammatory cells. The small area of stromal tissue present is positively labelled.100 H. JONES et al.
normal to the malignant state, demonstrated an increased
pattern of epithelial labelling corresponding to the severity of
the dysplasia. A subjective method was used to assess the
antigen concentration; this was generally at higher levels in
CIN 2 and 3 and in the invasive carcinomas although some
benign lesions were also significantly labelled.
The precise cellular distribution of the 5T4 Ag is difficult
to assess on frozen sections; however, there was evidence for
both cytoplasmic and membranous labelling in' the cervical
biopsy sections. There is a fundamental drawback to using
frozen material since if the Ag had a soluble nature, this
might leach during cutting and slide processing. Clearly,
conventionally fixed specimens would be much more in-
formative but the antigen does not survive the dewaxing
procedures necessary. Second generation reagents made to
the purified molecules may be helpful. Equally, if secretion of
the Ag occurs, then it would probably be from the lower
layers of the dysplastic cells in the epidermis, as the pattern
of staining was different from that of Cal which is secreted
at the luminal surface. This may account for the correlation
of basal epithelial cells level of expression and that seen in
the stroma of these cervical specimens.
The behaviour of the dysplastic process is unpredictable
and the lesion may persist or regress, and no morphological
or other criteria have as yet been able to predict the outcome
of the process (Stern & Neely, 1964). There appears to be a
correlation of general increase in intensity and extent of 5T4
expression in the more dysplastic conditions. There are
clearly individual examples from both putatively normal non-
dysplastic conditions and pre-malignant specimens which do
not fit this pattern, but all invasive carcinomas were positive
and there were 14/15 CIN 3 compared with 2/9 'normal'
ectocervical specimens showing any labelling throughout the
epithelium. However, some other benign lesions of the cervix
also showed full thickness staining. There are many reasons
for patients to seek advice and for gynaecologists to take
biopsies which can then only be assessed by the histological
appearance. But removal of a biopsy is indicative of an
abnormal presentation which warranted this invasive proce-
dure.
Galvin et al. (1985) showed that 53.9% of CIN I regressed
to normal epithelial types, and 16.6% progressed forward. In
CIN 3 samples, he stated that only 17.1% regressed and the
rest progressed. On the basis of this observation, more CIN 1
lesions would show a reduced 5T4 pattern of labelling com-
pared to the degree of dysplasia than in CIN 3 conditions.
Previous studies to investigate the prognostic significance of
other tumour antigens have used high (Ha) and low (La)
affinity Abs against CEA (Lindgren et al., 1985); the results
indicated that tissue CEA in patients with dysplasia did not
reflect malignant potential. By contrast, the data for the
degree of 5T4 antigen expression do appear to correlate with
malignant potential; it is tempting to speculate that the varia-
tion may reflect the natural history of the premalignant
conditions. Equally, the presence of HPV in the specimens
was attributed from the pathology and the absence of such
signs do not necessarily preclude the presence of this agent.
Indeed, the increasing evidence of the role of some papil-
lomavirus types in cervical cancer attracts the speculation
that in some cases, the increased 5T4 expression may result
from HPV infection directly. The use of DNA hybridisation
techniques (McCance et al., 1985) and 5T4 labelling will
resolve this question. The difference in HPV strains
associated with the different disease states of CIN may also
correlate with the 5T4 differential expression CIN I versus 2
and 3 (Brescia et al., 1986).
Since at least some common inflammatory conditions of
the cervix do show an enhanced 5T4 expression in the reserve
cell hyperplasia, it is possible that the increase in labelling
reflects the increased cell turnover. We also need to perform
detailed studies of the expression of 5T4 antigen in the other
parts of the genital tract. Nevertheless, using a sensitive
immunoassay it will be possible to investigate whether the
changes monitored in cervical biopsies by immunohisto-
chemistry might be reflected quantitatively by 5T4 antigenic
levels in cervical smear material. There are clearly other
conditions of the cervix which need to be included in such a
study including correlation with particular HPV type of
infection (Brescia ct al., 1986), Chlamydia (Hare ct al., 1982)
and herpes simplex (Kawana ct al., 1980). Cyclical variation
in antigen expression (McLaughlin el al., 1987) must also be
monitored.
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